1887
  1. Home
  2. A-Z Publications
  3. Global Cardiology Science and Practice
  4. Volume 2014, Issue 4
  5. Article
Volume 2014, Issue 4
  • ISSN: 2305-7823
  • EISSN:

Abstract

Diabetic patients have higher risk of stroke when compared to non-diabetics and in 25% of patients the cause of stroke is unknown. Marfella et al hypothesized that subclinical episodes of atrial fibrillation may be a common etiologic factor. 464 type-2 diabetic patients were compared to 240 health controls and were followed-up for 37 months. Silent cerebral infarcts at baseline were more common among diabetic patients with silent AF (176 patients) when compared to non-silent AF group (288 patients) (61% vs. 29%; p < 0.001) and was associated with higher number of stroke at follow-up.

© 2014 Al Suwaidi J. licensee Bloomsbury Qatar Foundation Journals.
Loading

Article metrics loading...

/content/journals/10.5339/gcsp.2014.50
2015-02-01
2024-11-05
Loading full text...

Full text loading...

/deliver/fulltext/gcsp/2014/4/gcsp.2014.50.html?itemId=/content/journals/10.5339/gcsp.2014.50&mimeType=html&fmt=ahah

References

  1. The Emerging Risk Factors Collaboration. Diabetes mellitus, fasting blood glucose concentration, and the risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet. 2010; 375::2215–2222.
     [Google Scholar]
  2. Flaker G, Belew K, Beckman K, Vidaillet H, Kron J, Safford R, Mickel M, Barrell P, ffirm A. Investigators. Asymptomatic atrial fibrillation: Demographic features and prognostic information from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. Am Heart J. 2005; 149::657–663.
     [Google Scholar]
  3. Salam AM, Gersh BJ, AlBinali HA, Singh R PhD, Asaad N, Awad Al-Qahtani A, Al Suwaidi J. The prognostic implications of lack of palpitations in patients hospitalized with atrial fibrillation: Observations from a 20-year registry. Int J Clin Pract. 2014 Jan; 68:1:122–129.
     [Google Scholar]
  4. Marfella R, Sasso FC, Siniscalchi M, Cirillo M, Paolisso P, Sardu C, Barbieri M, Rizzo MR, Mauro C, Paolisso G. Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients. J Am Coll Cardiol. 2013; 62::525–530.
     [Google Scholar]
  5. Prystowsky EN, Padanilam BJ. Preserve the brain: Primary goal in the therapy of atrial fibrillation. J Am Coll Cardiol. 2013; 62::540–542.
     [Google Scholar]
  6. El-Menyar AA, Albinali HA, Bener A, Mohammed I, Al Suwaidi J. Prevalence and impact of diabetes mellitus in patients with acute myocardial infarction: A 10-year experience. Angiology. 2009 Dec-2010 Jan; 60:6:683–688.
     [Google Scholar]
  7. Kaba Riyaz A, Cannie D, Ahmed O. RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation. Global Cardiology Science and Practice. 2014; 2::26.
     [Google Scholar]
  8. Kaba Riyaz A, Ahmed O, Cannie D. ENGAGE AF: Effective anticoagulation with factor Xa in next generation treatment of atrial fibrillation. Global Cardiology Science and Practice. 2013; 4::41.
     [Google Scholar]
/content/journals/10.5339/gcsp.2014.50
Loading
Diabetes and silent atrial fibrillation: A dangerous liaison?
Global Cardiology Science and Practice 2014, 50 (2015); https://doi.org/10.5339/gcsp.2014.50
/content/journals/10.5339/gcsp.2014.50
/content/journals/10.5339/gcsp.2014.50
Loading

Data & Media loading...

  • Article Type: Research Article
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error